We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+4.68%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$274M
AUM Growth
-$226M
Cap. Flow
-$218M
Cap. Flow %
-79.62%
Top 10 Hldgs %
48.16%
Holding
77
New
14
Increased
9
Reduced
38
Closed
15

Top Buys

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$5.15M
2
CPAY icon
Corpay
CPAY
+$4.93M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$4.51M
4
VIPS icon
Vipshop
VIPS
+$3.73M
5
PHM icon
Pultegroup
PHM
+$3.22M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$18.8M
2
WBA
Walgreens Boots Alliance
WBA
+$17.8M
3
MCK icon
McKesson
MCK
+$15.3M
4
BKNG icon
Booking.com
BKNG
+$14.9M
5
RAD
Rite Aid Corporation
RAD
+$14.8M

Sector Composition

Rank Sector Weight
1 Healthcare 24.49%
2 Communication Services 22.64%
3 Materials 11.25%
4 Technology 10.65%
5 Energy 5.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TIBX
26
DELISTED
TIBCO SOFTWARE INC
TIBX
$4.97M 1.82%
210,205
-162,930
-44% -$3.33M
CYH icon
27
Community Health Systems
CYH
$416M
$4.34M 1.59%
95,793
-15,776
-14% -$656K
TCOM icon
28
Trip.com Group
TCOM
$29.1B
$3.99M 1.46%
140,492
-120,390
-46% -$3.82M
VIPS icon
29
Vipshop
VIPS
$7.4B
$3.42M 1.25%
+180,910
New +$3.73M
TWX
30
DELISTED
Time Warner Inc
TWX
$2.43M 0.89%
+32,305
New +$2.5M
MDVN
31
DELISTED
MEDIVATION, INC.
MDVN
$2.11M 0.77%
42,656
-249,864
-85% -$10.6M
CLVS
32
DELISTED
Clovis Oncology, Inc.
CLVS
$1.67M 0.61%
36,798
+20,084
+120% +$839K
ACOR
33
DELISTED
Acorda Therapeutics
ACOR
$950K 0.35%
+234
New +$878K
MCK icon
34
McKesson
MCK
$102B
$826K 0.3%
4,242
-79,604
-95% -$15.3M
HNT
35
DELISTED
HEALTH NET INC
HNT
$800K 0.29%
17,346
-13,869
-44% -$616K
KPTI icon
36
Karyopharm Therapeutics
KPTI
$44.2M
$753K 0.28%
1,437
-224
-13% -$126K
KYTH
37
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$735K 0.27%
22,443
-13,730
-38% -$484K
ZSPH
38
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$655K 0.24%
+16,708
New +$552K
HUM icon
39
Humana
HUM
$44.1B
$652K 0.24%
5,001
-1,456
-23% -$185K
ANAC
40
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$569K 0.21%
23,258
-16,671
-42% -$339K
THC icon
41
Tenet Healthcare
THC
$20.7B
$529K 0.19%
8,901
-12,977
-59% -$724K
A icon
42
Agilent Technologies
A
$39.9B
$522K 0.19%
12,803
-231,193
-95% -$9.44M
OCR
43
DELISTED
OMNICARE INC
OCR
$516K 0.19%
8,281
-1,939
-19% -$123K
OREX
44
DELISTED
Orexigen Therapeutics, Inc.
OREX
$455K 0.17%
10,682
-6,570
-38% -$353K
MDCO
45
DELISTED
Medicines Co
MDCO
$454K 0.17%
20,342
+2,245
+12% +$57K
ACAD icon
46
Acadia Pharmaceuticals
ACAD
$4.9B
$319K 0.12%
12,865
-48,507
-79% -$1.13M
ALDR
47
DELISTED
Alder Biopharmaceuticals
ALDR
$300K 0.11%
23,660
-4,233
-15% -$64K
RLYP
48
DELISTED
RELYPSA INC COM
RLYP
$284K 0.1%
+13,489
New +$327K
HOLX
49
DELISTED
Hologic
HOLX
$270K 0.1%
+11,109
New +$281K
BRKR icon
50
Bruker
BRKR
$7.8B
$258K 0.09%
13,957
-9,530
-41% -$204K
1
2
3 4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q3 2014 Portfolio in Review

As of Q3 2014, Partner Investment Management held 77 positions worth $274M, down 45% from $499M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Partner Investment Management withdrew a net $218M in Q3 2014, closing 15 positions and reducing 38 holdings. Its most notable exit was Walgreens Boots Alliance, an estimated $17.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 32% a quarter earlier, followed by Communication Services and Materials.

Against the trend, Partner Investment Management opened a new position in Corpay worth $5.09M.

  • Partner Investment Management's largest Q3 2014 buy was Corpay: 35,823 shares worth $5.09M.
  • Partner Investment Management added most to Baidu in Q3 2014, an estimated $5.15M increase.
  • Partner Investment Management's biggest Q3 2014 reduction was Allergan Inc, cutting an estimated $18.8M.
  • Partner Investment Management fully exited Walgreens Boots Alliance in Q3 2014, selling an estimated $17.8M.
  • Partner Investment Management's ten largest holdings make up 48% of its $274M portfolio in Q3 2014.
  • Partner Investment Management opened 14 new positions and closed 15 in Q3 2014.
  • Partner Investment Management's portfolio value fell 45% quarter-over-quarter to $274M.

Based on Partner Investment Management's 13F filing for Q3 2014, filed 14 Nov 2014.